BLOOD PRESSURE AND PLASMA FGF-23 CONCENTRATION CHANGES AFTER CINACALCET TREATMENT IN HEMODIALYZED PATIENTS WITH CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYROIDISM

被引：0
|
作者：
Adamczak, M. [1 ]
Kuczera, P. [1 ]
Wiecek, A. [1 ]
机构：
[1] Dept Nephrol Transplantol & Internal Med, Katowice, Poland
来源：
JOURNAL OF HYPERTENSION | 2015年 / 33卷
关键词：
D O I：
10.1097/01.hjh.0000468926.58110.3f
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PP.39.14
引用
收藏
页码：E488 / E489
页数：2
相关论文
共 50 条
  • [1] IS THERE RELATIONSHIP BETWEEN BLOOD PRESSURE AND PLASMA FGF-23 CONCENTRATION CHANGES AFTER CINACALCET TREATMENT IN HEMODIALYSED PATIENTS WITH CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYROIDISM?
    Kuczera, Piotr
    Adamczak, Marcin
    Wiecek, Andrzej
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [2] CINACALCET DECREASES PLASMA FGF-23 CONCENTRATION IN HEMODIALYSED PATIENTS WITH CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYROIDISM
    Adamczak, Marcin
    Wiecek, Andrzej
    Kuczera, Piotr
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 463 - 463
  • [3] TREATMENT WITH CINACALCET INCREASES PLASMA ADIPONECTIN CONCENTRATION IN HEMODIALYZED PATIENTS WITH CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYROIDISM
    Kuczera, Piotr
    Adamczak, Marcin
    Machnik, Grzegorz
    Okopien, Boguslaw
    Wiecek, Andrzej
    ENDOCRINE PRACTICE, 2015, 21 (07) : 743 - 749
  • [4] FGF-23 and secondary hyperparathyroidism in chronic kidney disease
    Justin Silver
    Tally Naveh-Many
    Nature Reviews Nephrology, 2013, 9 : 641 - 649
  • [5] FGF-23 and secondary hyperparathyroidism in chronic kidney disease
    Silver, Justin
    Naveh-Many, Tally
    NATURE REVIEWS NEPHROLOGY, 2013, 9 (11) : 641 - 649
  • [6] Cinacalcet lowers FGF-23 level together with bone metabolism in hemodialyzed patients with secondary hyperparathyroidism
    Hryszko, Tomasz
    Brzosko, Szymon
    Rydzewska-Rosolowska, Alicja
    Koc-Zorawska, Ewa
    Mysliwiec, Michal
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2012, 44 (05) : 1479 - 1486
  • [7] Cinacalcet lowers FGF-23 level together with bone metabolism in hemodialyzed patients with secondary hyperparathyroidism
    Tomasz Hryszko
    Szymon Brzosko
    Alicja Rydzewska-Rosolowska
    Ewa Koc-Zorawska
    Michal Mysliwiec
    International Urology and Nephrology, 2012, 44 : 1479 - 1486
  • [8] Cinacalcet treatment decreases plasma fibroblast growth factor 23 concentration in haemodialysed patients with chronic kidney disease and secondary hyperparathyroidism
    Kuczera, Piotr
    Adamczak, Marcin
    Wiecek, Andrzej
    CLINICAL ENDOCRINOLOGY, 2014, 80 (04) : 607 - 612
  • [9] TREATMENT WITH CINACALCET INCREASES PLASMA ADIPONECTIN CONCENTRATION IN HEMODIALYSED PATIENTS WITH CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYROIDISM
    Kuczera, Piotr
    Adamczak, Marcin
    Machnik, Grzegorz
    Okopien, Boguslaw
    Wiecek, Andrzej
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [10] Treatment with cinacalcet decreases systolic blood pressure in haemodialysed patients with chronic kidney disease and secondary hyperparathyroidism
    Kuczera, Piotr
    Adamczak, Marcin
    Wiecek, Andrzej
    ARTERIAL HYPERTENSION, 2015, 19 (03): : 129 - 134
12345